68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau DiseaseBanezhad, Farnaz, MD*; Kiamanesh, Zahra, MD*; Emami, Farshad, MD†; Sadeghi, Ramin, MD*Clinical Nuclear Medicine: June 2019 - Volume 44 - Issue 6 - p e385–e387 doi: 10.1097/RLU.0000000000002565 Interesting Images Buy Abstract Author InformationAuthors Article MetricsMetrics Von Hippel-Lindau disease is an inherited syndrome associated with several benign and malignant tumors such as central nervous system (CNS) hemangioblastoma. Herein, we report a known case of A Von Hippel-Lindau patient with a cerebral hemangioblastoma who was referred for further evaluation because of recent paraparesis. 18F-FDG PET/CT showed no focal uptake in the thoracic spine, which demonstrated increased 68Ga DOTATATE activity, owing to overexpression of somatostatin receptors, suggesting spinal cord hemangioblastoma. This case report indicates the significant role of 68Ga-labeled somatostatin receptor analogs in the diagnosis of hemangioblastoma. From the *Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad; and †Nuclear Medicine & Molecular Imaging Department, Imam Reza International University, Mashhad, Iran. Conflicts of interest and sources of funding: none declared. Received for publication August 7, 2018; revision accepted February 18, 2019. Correspondence to: Ramin Sadeghi, MD, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. E-mail: email@example.com; firstname.lastname@example.org. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.